首页> 美国卫生研究院文献>International Journal of Health Policy and Management >Moving Towards Accountability for Reasonableness – A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study
【2h】

Moving Towards Accountability for Reasonableness – A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study

机译:迈向合理性的责任追究制–以罕见病和再生疗法为例对合法医疗保险决策流程特征的系统研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: The accountability for reasonableness (A4R) framework defines 4 conditions for legitimate healthcare coverage decision processes: Relevance, Publicity, Appeals, and Enforcement. The aim of this study was to reflect on how the diverse features of decision-making processes can be aligned with A4R conditions to guide decision-making towards legitimacy. Rare disease and regenerative therapies (RDRTs) pose special decision-making challenges and offer therefore a useful case study. >Methods: Features operationalizing each A4R condition as well as three different approaches to address these features (cost-per-QALY-focused and multicriteria-based) were defined and organized into a matrix. Seven experts explored these features during a panel run under the Chatham House Rule and provided general and RDRT-specific recommendations. Responses were analyzed to identify converging and diverging recommendations. >Results: Regarding Relevance, recommendations included supporting deliberation, stakeholder participation and grounding coverage decision criteria in normative and societal objectives. Thirteen of 17 proposed decision criteria were recommended by a majority of panelists. The usefulness of universal cost-effectiveness thresholds to inform allocative efficiency was challenged, particularly in the RDRT context. RDRTs raise specific issues that need to be considered; however, rarity should be viewed in relation to other aspects, such as disease severity and budget impact. Regarding Publicity, panelists recommended transparency about the values underlying a decision and value judgements used in selecting evidence. For Appeals, recommendations included a life-cycle approach with clear provisions for re-evaluations. For Enforcement, external quality reviews of decisions were recommended. >Conclusion: Moving coverage decision-making processes towards enhanced legitimacy in general and in the RDRT context involves designing and refining approaches to support participation and deliberation, enhancing transparency, and allowing explicit consideration of multiple decision criteria that reflect normative and societal objectives.
机译:>背景:合理性责任制(A4R)框架为合法的医疗保险决策流程定义了4个条件:相关性,宣传性,上诉性和执行性。这项研究的目的是思考决策过程的各种特征如何与A4R条件相结合,以指导决策朝着合法性发展。罕见病和再生疗法(RDRT)构成了特殊的决策挑战,因此提供了有用的案例研究。 >方法:定义了可操作每种A4R条件的功能以及解决这些功能的三种不同方法(以按QALY为基础的费用和基于多标准的费用)并将其组织成一个矩阵。在Chatham House规则下的小组讨论中,七位专家探讨了这些功能,并提供了一般性建议和RDRT特定的建议。分析了答复,以确定趋同和分歧的建议。 >结果:关于相关性,建议包括支持在规范目标和社会目标中进行审议,利益相关者参与以及将覆盖范围决策标准作为基础。大多数小组成员推荐了17个提议的决策标准中的13个。普遍成本效益阈值对于分配效率的实用性受到了挑战,特别是在RDRT的情况下。 RDRT提出了需要考虑的特定问题;但是,应与其他方面(例如疾病严重程度和预算影响)联系起来,来考虑罕见性。关于公开,小组成员建议对决策依据和选择证据时使用的价值判断的价值保持透明。对于上诉,建议包括生命周期方法,并为重新评估提供了明确的规定。对于执法,建议对决策进行外部质量审查。 >结论:将覆盖范围决策过程总体上和在RDRT范围内提高合法性涉及设计和完善支持参与和审议的方法,增强透明度并允许明确考虑反映规范的多个决策标准和社会目标。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号